首页 | 本学科首页   官方微博 | 高级检索  
检索        

叶酸修饰的聚乙烯亚胺聚合物载PD-L1 siRNA体外靶向胃癌细胞的研究
引用本文:罗信,彭霞,陈广成,侯婧瑛,吴淑云,王凌云.叶酸修饰的聚乙烯亚胺聚合物载PD-L1 siRNA体外靶向胃癌细胞的研究[J].中国病理生理杂志,2017,33(12):2179-2187.
作者姓名:罗信  彭霞  陈广成  侯婧瑛  吴淑云  王凌云
作者单位:1. 中山大学孙逸仙纪念医院消化内科, 广东 广州 510120;
2. 中山大学孙逸仙纪念医院急诊科, 广东 广州 510120;
3. 中山大学肿瘤防治中心胸外科, 广东 广州 510060
基金项目:广州市科技计划项目(No.201704020121)
摘    要:目的:构建高效的siRNA纳米载体靶向SGC-7901胃癌细胞,并下调胃癌表达的程序性死亡配体1(PD-L1)。方法:检测叶酸(FA)-PEG-SS-PEI-SPION纳米载体与siRNA复合后的粒径、电位等表征;体外实验检验siRNA的结合能力、复合物细胞毒性、细胞摄入能力及转染效率;磁共振(MR)成像检测示踪能力;检验胃癌细胞PD-L1下调效应及共培养T细胞的细胞因子水平。结果:N/P比值为10时,FA-PEG-SS-PEI-SPION完全复合siRNA,形成电位为(9.14±0.80)m V、粒径为(116.7±2.5)nm的多聚复合物。靶向组的转染率为(95.06±0.44)%,与非靶向组的(93.87±1.05)%相当;平均荧光强度为1 892.67±81.51,高于非靶向组的1 324.33±186.58(P0.05)。普鲁士蓝染色和激光共聚焦显微镜成像证实了复合物的细胞摄入。体外MR成像验证了聚合物的MR造影成像能力。靶向组PD-L1的mRNA最低相对表达量为9.07%±0.79%,Western blot显示PD-L1的表达显著降低。共培养实验显示IFN-γ和TNF-α的分泌水平增加,IL-10的分泌水平降低(P0.05)。结论:本研究构建了FA-PEG-SS-PEI-SPION纳米载体,并证明了其体外靶向细胞及载siRNA下调PD-L1表达的能力和MR示踪的能力,是一种高效和安全的靶向治疗纳米载体。

关 键 词:程序性死亡配体1  胃癌  叶酸  磁共振成像  siRNA  
收稿时间:2017-03-03

Using folic acid-modified polyethylenimine-SPIO nanoparticles for PD-L1 siRNA delivery to target gastric cancer
LUO Xin,PENG Xia,CHEN Guang-cheng,HOU Jing-ying,WU Shu-yun,WANG Ling-yun.Using folic acid-modified polyethylenimine-SPIO nanoparticles for PD-L1 siRNA delivery to target gastric cancer[J].Chinese Journal of Pathophysiology,2017,33(12):2179-2187.
Authors:LUO Xin  PENG Xia  CHEN Guang-cheng  HOU Jing-ying  WU Shu-yun  WANG Ling-yun
Institution:1. Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China;
2. Department of Emergency Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China;
3. Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
Abstract:AIM: To synthesis and characterize a multi-functional siRNA delivery agent with effective therapeutic effects and MR-tracing ability for programmed death ligand-1 (PD-L1) positive gastric cancer SGC-7901 cell line. METHODS: The characterization, binding ability, cytotoxicity, transfection efficiency and cellular internalization of the polyplex were determined. The PD-L1 knockdown effect was analyzed, and cytokines secreted by cocultured T cells were measured.RESULTS: We developed folic acid (FA)-PEG-SS-PEI-SPION as siRNA delivery agent for PD-L1 knockdown. At N/P ratio of 10, the FA-PEG-SS-PEI-SPION bound PD-L1 siRNA to form polyplex in a diameter of (116.7±2.5) nm with zeta potential of (9.14±0.80) mV. Transfection efficiency of the targeted polyplex was (95.06±0.44)%, compared with (93.87±1.05)% of the untargeted polyplex. Mean fluorescence intensity of the targeted polyplex was 1 892.67±81.51, significantly higher than 1 324.33±186.58 of the untargeted. The cellular magnetic resonance (MR) imaging showed the polyplex also acted as T2 weighted contrast agent for cancer MR imaging. The relative mRNA level of PD-L1 in polymer/siRNA-2 treatment group was (9.07±0.79)%. Decreased protein expression of PD-L1 was showed by Western blot. The secretion levels of IFN-γ and TNF-α in cocultured T cells increased, while that of IL-10 decreased. CONCLUSION: Our findings highlighted the potential of the multifunctional theranostic nanoparticles for effective targeting PD-L1 knockdown therapy and MR imaging diagnosis in gastric cancers.
Keywords:Programmed death ligand-1  Gastric cancer  Folic acid  Magnetic resonance imaging  siRNA
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号